CBD hemp oil and CBD paste and The fight against schizophrenia

Cannabidiol (CBD) as a potential treatment for psychosis

Cannabidiol found e.g. in hemp oil with CBD has antipsychotic properties. This publication succinctly describes the role of the endocannabinoid system in the development of psychosis and clearly shows that CBD can be used as a potential drug to combat this disease.

Cannabidiol increases anandamide signaling and relieves the psychotic symptoms of schizophrenia.

Clinical trials using amisulpride (a powerful drug used to treat chronic and acute schizophrenia) and cannabidiol CBD in schizophrenia. Studies have shown that in the case of CBD (high content, e.g. hemp paste 30%) we are dealing with a significant clinical improvement and with reduced side effects compared to amisulpride.

Cannabidiol

Medical use of cannabis. Cannabidiol - a new hope for schizophrenia ?

Evidence suggests that CBD (e.g., hemp-based oil) may benefit the "positive" and "negative" symptoms of schizophrenia. Neurochemical behaviors and models suggest that cannabidiol has a pharmacological profile similar to atypical antipsychotics. During clinical trials, it was found that cannabinoids are a well-tolerated alternative for the treatment of schizophrenia.

Cannabinoids and schizophrenia : therapeutic perspectives

The publication shows how important the endocannabinoid system (ECS) is in the normal functioning of our body. He is responsible, among other things, for maintaining a normal state of mental health. Preliminary data show that CBD products use affect its process and its proper operation.